• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症化学预防:经验教训与未来方向。

Cancer chemoprevention: lessons learned and future directions.

作者信息

Brenner D E, Gescher A J

机构信息

Division of Hematology-Oncology, Department of Internal Medicine, University of Michigan & VA Medical Center, Ann Arbor, 48109, 0930, USA.

出版信息

Br J Cancer. 2005 Oct 3;93(7):735-9. doi: 10.1038/sj.bjc.6602765.

DOI:10.1038/sj.bjc.6602765
PMID:16160697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2361630/
Abstract

The concept of delaying or preventing epithelial transformation remains a viable and attainable goal for the future. Drug-based strategies for chemoprevention of the future may predominantly rely upon targeted therapies with tolerable but defined toxicities for treatment of individuals diagnosed with intraepithelial neoplasias. Foods, diet manipulation strategies, or nutraceuticals may be more appropriate to delay or prevent carcinogenesis progression in healthy populations with genetic or epidemiologic evidence of risk for future transformation.

摘要

延迟或预防上皮化生的概念仍是未来一个可行且可实现的目标。未来基于药物的化学预防策略可能主要依赖于靶向治疗,这种治疗对诊断为上皮内瘤变的个体具有可耐受但明确的毒性。对于有未来化生风险的遗传或流行病学证据的健康人群,食物、饮食调控策略或营养保健品可能更适合延迟或预防癌症进展。

相似文献

1
Cancer chemoprevention: lessons learned and future directions.癌症化学预防:经验教训与未来方向。
Br J Cancer. 2005 Oct 3;93(7):735-9. doi: 10.1038/sj.bjc.6602765.
2
Chemoprevention of cancer.癌症的化学预防
CA Cancer J Clin. 2004 May-Jun;54(3):150-80. doi: 10.3322/canjclin.54.3.150.
3
How can components of common foods affect cancer risk?常见食物的成分如何影响患癌风险?
Mol Med Today. 1997 Mar;3(3):103-7. doi: 10.1016/s1357-4310(97)01002-2.
4
Chemoprevention of lung cancer.肺癌的化学预防
Lancet Oncol. 2003 Nov;4(11):659-69. doi: 10.1016/s1470-2045(03)01244-0.
5
Cancer chemoprevention. A new way to treat cancer before it happens.癌症化学预防。一种在癌症发生前进行治疗的新方法。
Prim Care. 1998 Jun;25(2):361-79. doi: 10.1016/s0095-4543(05)70069-5.
6
Genetic and epigenetic cancer chemoprevention on molecular targets during multistage carcinogenesis.多阶段致癌过程中基于分子靶点的遗传和表观遗传癌症化学预防。
Arch Toxicol. 2016 Oct;90(10):2389-404. doi: 10.1007/s00204-016-1813-9. Epub 2016 Aug 19.
7
Properties of intraepithelial neoplasia relevant to cancer chemoprevention and to the development of surrogate end points for clinical trials.与癌症化学预防及临床试验替代终点的发展相关的上皮内瘤变的特性。
Proc Soc Exp Biol Med. 1997 Nov;216(2):151-65. doi: 10.3181/00379727-216-44165.
8
Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.用于大规模化学预防试验的队列选择的癌症风险因素。
J Cell Biochem Suppl. 1996;25:29-36.
9
Chemoprevention targets for tobacco-related head and neck cancer: past lessons and future directions.烟草相关头颈癌的化学预防靶点:过去的经验教训与未来方向
Oral Oncol. 2015 Jun;51(6):557-64. doi: 10.1016/j.oraloncology.2015.02.101. Epub 2015 Apr 11.
10
Cancer chemoprevention: how do we know what works?癌症化学预防:我们如何知晓何种方法有效?
J Clin Oncol. 2007 Apr 20;25(12):1461-2. doi: 10.1200/JCO.2006.10.3648.

引用本文的文献

1
Effect of Gut Microbiota Biotransformation on Dietary Tannins and Human Health Implications.肠道微生物群生物转化对膳食单宁的影响及其对人类健康的意义。
Microorganisms. 2021 Apr 29;9(5):965. doi: 10.3390/microorganisms9050965.
2
The Immunomodulatory and Anti-Inflammatory Role of Polyphenols.多酚的免疫调节和抗炎作用。
Nutrients. 2018 Nov 2;10(11):1618. doi: 10.3390/nu10111618.
3
Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention.通过芹菜素靶向 PI3K/Akt/mTOR 轴预防癌症。
Anticancer Agents Med Chem. 2013 Sep;13(7):971-8. doi: 10.2174/18715206113139990119.
4
NO-donating aspirin inhibits the activation of NF-kappaB in human cancer cell lines and Min mice.释放一氧化氮的阿司匹林可抑制人癌细胞系和Min小鼠中NF-κB的激活。
Carcinogenesis. 2008 Feb;29(2):390-7. doi: 10.1093/carcin/bgm275. Epub 2008 Jan 3.
5
Antimutagenicity of cinnamaldehyde and vanillin in human cells: Global gene expression and possible role of DNA damage and repair.肉桂醛和香草醛对人细胞的抗诱变作用:全基因组表达以及DNA损伤与修复的可能作用
Mutat Res. 2007 Mar 1;616(1-2):60-9. doi: 10.1016/j.mrfmmm.2006.11.022. Epub 2006 Dec 18.

本文引用的文献

1
Statins and the risk of colorectal cancer.他汀类药物与结直肠癌风险
N Engl J Med. 2005 May 26;352(21):2184-92. doi: 10.1056/NEJMoa043792.
2
A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.一项关于抗氧化维生素预防头颈癌患者二次原发性癌症的随机试验。
J Natl Cancer Inst. 2005 Apr 6;97(7):481-8. doi: 10.1093/jnci/dji095.
3
The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer.BCPT症状量表:一种用于诊断患有乳腺癌或有乳腺癌风险的女性的身体症状测量工具。
J Natl Cancer Inst. 2005 Mar 16;97(6):448-56. doi: 10.1093/jnci/dji069.
4
What happened to the coxibs on the way to the cardiologist?昔布类药物在通往心脏病专家的路上出了什么事?
Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):555-6. doi: 10.1158/1055-9965.EPI-14-3-EDA.
5
COX-2 inhibitors--a lesson in unexpected problems.环氧化酶-2抑制剂——一个有关意外问题的教训。
N Engl J Med. 2005 Mar 17;352(11):1131-2. doi: 10.1056/NEJMe058038. Epub 2005 Feb 15.
6
Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.心脏手术后COX-2抑制剂帕瑞昔布和伐地昔布的并发症。
N Engl J Med. 2005 Mar 17;352(11):1081-91. doi: 10.1056/NEJMoa050330. Epub 2005 Feb 15.
7
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.在一项预防结直肠腺瘤的临床试验中与塞来昔布相关的心血管风险。
N Engl J Med. 2005 Mar 17;352(11):1071-80. doi: 10.1056/NEJMoa050405. Epub 2005 Feb 15.
8
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.一项结直肠腺瘤化学预防试验中与罗非昔布相关的心血管事件。
N Engl J Med. 2005 Mar 17;352(11):1092-102. doi: 10.1056/NEJMoa050493. Epub 2005 Feb 15.
9
Polyphenolic phytochemicals versus non-steroidal anti-inflammatory drugs: which are better cancer chemopreventive agents?多酚类植物化学物质与非甾体抗炎药:哪种是更好的癌症化学预防剂?
J Chemother. 2004 Nov;16 Suppl 4:3-6. doi: 10.1179/joc.2004.16.Supplement-1.3.
10
Innovative agents in cancer prevention.癌症预防中的创新药物。
Recent Results Cancer Res. 2005;166:257-75. doi: 10.1007/3-540-26980-0_17.